João Pedro Ferreira1, Patrick Rossignol2, Pooja Dewan3, Zohra Lamiral2, William B White4, Bertram Pitt5, John J V McMurray3, Faiez Zannad6. 1. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal. 2. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. 3. Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. 4. Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT. 5. University of Michigan School of Medicine, Ann Arbor, MI. 6. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. Electronic address: f.zannad@chru-nancy.fr.
Abstract
BACKGROUND: Analyses of country or regional differences in cardiovascular (CV) trials are based on geographical subgroup analyses. However, apart from map location and related racial, ethnic, and genetic variations, identified differences may also depend on social structure and provision and access to health care, for which country income and income inequality are indicators. The aim of the study was to examine the association between country per capita income and income inequality and prognosis in patients with heart failure or an acute coronary syndrome in 3 international trials (EMPHASIS-HF, EPHESUS, and EXAMINE). METHODS: Countries were classified into high income or low-middle income (LMICs) and into low, middle, or high inequality using the Gini index. The main outcome measures were all-cause and CV death. RESULTS: Patients from LMICs and countries with higher inequality were younger, were less often white, had fewer comorbid conditions, and were less often treated with guideline-recommended therapies, including devices. These patients had higher adjusted mortality rates (+15% to +70%) compared with patients from high-income countries and countries with less inequality. Patients from countries with the combination of greater inequality and low-middle income had particularly high mortality rates (+80% to +190%) compared with those that did not have both characteristics. Living in a country that is poor and has inequality had more impact on death rates than any comorbidity. These findings were reproduced in 3 trials. CONCLUSIONS: Patients from LMICs and countries with greater inequality had the highest mortality rates. The prognostic impact of income and inequality is substantial and should be considered when looking into subgroup differences in CV trials.
BACKGROUND: Analyses of country or regional differences in cardiovascular (CV) trials are based on geographical subgroup analyses. However, apart from map location and related racial, ethnic, and genetic variations, identified differences may also depend on social structure and provision and access to health care, for which country income and income inequality are indicators. The aim of the study was to examine the association between country per capita income and income inequality and prognosis in patients with heart failure or an acute coronary syndrome in 3 international trials (EMPHASIS-HF, EPHESUS, and EXAMINE). METHODS: Countries were classified into high income or low-middle income (LMICs) and into low, middle, or high inequality using the Gini index. The main outcome measures were all-cause and CV death. RESULTS:Patients from LMICs and countries with higher inequality were younger, were less often white, had fewer comorbid conditions, and were less often treated with guideline-recommended therapies, including devices. These patients had higher adjusted mortality rates (+15% to +70%) compared with patients from high-income countries and countries with less inequality. Patients from countries with the combination of greater inequality and low-middle income had particularly high mortality rates (+80% to +190%) compared with those that did not have both characteristics. Living in a country that is poor and has inequality had more impact on death rates than any comorbidity. These findings were reproduced in 3 trials. CONCLUSIONS:Patients from LMICs and countries with greater inequality had the highest mortality rates. The prognostic impact of income and inequality is substantial and should be considered when looking into subgroup differences in CV trials.
Authors: Gabriela Miana de Mattos Paixão; Emilly M Lima; André B Quadros; Daniel P R Cabral; Renato R Coelho; Derick M Oliveira; Jamil de Souza Nascimento; Paulo R Gomes; Antonio L Ribeiro Journal: Arq Bras Cardiol Date: 2022-07-18 Impact factor: 2.667
Authors: Jie Wei Zhu; NhatChinh Le; Sunny Wei; Liesl Zühlke; Renato D Lopes; Faiez Zannad; Harriette G C Van Spall Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-09-05
Authors: Priya Vart; Ricardo Correa-Rotter; Fan Fan Hou; Niels Jongs; Glenn M Chertow; Anna Maria Langkilde; John J V McMurray; Peter Rossing; C David Sjöström; Bergur V Stefansson; Robert D Toto; Walter Douthat; Elizabeth Escudero; Rey Isidto; Dinesh Khullar; Harpreet S Bajaj; David C Wheeler; Hiddo J L Heerspink Journal: Kidney Int Rep Date: 2022-02-02
Authors: Khalid F Alhabib; Habib Gamra; Wael Almahmeed; Ayman Hammoudeh; Salim Benkheddah; Mohammad Al Jarallah; Ahmed Al-Motarreb; Mothanna Alquraishi; Mohamed Sobhy; Magdi G Yousif; Fahad Alkindi; Nadia Fellat; Mohammad I Amin; Muhammad Ali; Ayman Al Saleh; Anhar Ullah; Faiez Zannad Journal: PLoS One Date: 2020-07-22 Impact factor: 3.240
Authors: Héctor González-Pacheco; Amada Álvarez-Sangabriel; Carlos Martínez-Sánchez; José L Briseño-Cruz; Alfredo Altamirano-Castillo; Salvador Mendoza-García; Daniel Manzur-Sandoval; Luis M Amezcua-Guerra; Julio Sandoval; Rafael Bojalil; Diego Araiza-Garaygordobil; Daniel Sierra-Lara; Carlos A Guiza-Sánchez; Rodrigo Gopar-Nieto; Camelia Cruz-Rodríguez; José J Valdivia-Nuño; Brandon Salas-Teles; Alexandra Arias-Mendoza Journal: ESC Heart Fail Date: 2020-11-11
Authors: Carolyn S P Lam; João Pedro Ferreira; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Naveed Sattar; Subodh Verma; Martina Brueckmann; Janet Schnee; Daniel Cotton; Faiez Zannad; Milton Packer Journal: Eur Heart J Date: 2021-11-14 Impact factor: 29.983